This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the dermatology devices market, along with revenue estimates & forecasts and market share analysis.

The global dermatology devices market is expected to reach USD 14.17 Billion by 2021 from USD 8.22 Billion in 2016, at a CAGR of 11.50% during the forecast period. The rising incidence of skin disorders, increasing awareness on aesthetic procedures, technological advancements, and increasing healthcare expenditure are the major factors driving the growth of this market.

The global dermatology devices market is segmented into diagnostic devices (by type and application) and treatment devices (by type and application). Based on the type of diagnostic devices, the dermatology devices market is segmented into dermatoscopes, microscopes, and imaging devices. The imaging devices segment is expected to account for the largest share of the market during the forecast period. The large share of this segment can be attributed to technological advancements and increasing awareness about the available aesthetic procedures in the market.

On the basis of the type of treatment devices, the dermatology devices market is segmented into light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion devices, and cryotherapy devices. In 2016, the light therapy devices segment is expected to account for the largest share primarily due to the increasing incidence of skin diseases and technological advancements.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=154

On the basis of the application of diagnostic devices, the dermatology devices market is segmented into skin cancer diagnosis and other diagnostic applications. The skin cancer diagnosis segment is expected to account for the largest share in 2016. The rising incidence of skin disorders is the major factor driving the growth of this market.

On the basis of the application of treatment devices, the dermatology devices market is segmented into hair removal; skin rejuvenation; acne, psoriasis, and tattoo removal; wrinkle removal and skin resurfacing; body contouring and fat removal; vascular and pigmented lesion removal; warts, skin tags, and weight management; and other treatment applications. The other treatment applications segment is expected to account for the largest share of the market during the forecast period, primarily due to the increasing awareness about aesthetic procedures and technological advancements.

Based on region, the global dermatology devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is expected to witness the highest CAGR during the forecast period, with the growth in this market centered at Japan, China, and India. Growth in the Asian region is primarily driven by the rising incidence of skin diseases, increasing healthcare expenditure, and increasing awareness regarding aesthetic procedures.

Major players in the dermatology devices market include 3Gen, Inc. (U.S.), Alma Lasers, Ltd. (Israel), Bruker Corporation (U.S.), Carl Zeiss (Germany), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Genesis Biosystems (U.S.), HEINE Optotechnik GmbH & Co. KG (Germany), Lumenis, Ltd. (Israel), Michelson Diagnostics, Ltd. (U.K.), PhotoMedex, Inc. (U.S.), and Valeant Pharmaceuticals International, Inc. (Canada).

Based on the analysis of strategic developments undertaken by market players between 2012 and 2016, the key strategies followed by most companies in the dermatology devices market are product launches and acquisitions. Some of the leading players that adopted this strategy include Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Lumenis, Ltd. (Israel), 3Gen Inc. (U.S.) Valeant Pharmaceutical (Canada), Carl Zeiss (Germany), Genesis Biosystems, Inc. (U.S.), HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics (U.K.), and PhotoMedex, Inc. (U.S.).

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=154

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]